✦ LIBER ✦

Antipyrine clearance and response to interferon treatment in patients with chronic active hepatitis C

✍ Scribed by Shirley Coverdale; Karen Byth; Jacqueline Field; Christopher Liddle; Rita Lin; Professor Geoffrey C. Farrell

Publisher: John Wiley and Sons
Year: 1995
Tongue: English
Weight: 823 KB
Volume: 22
Category: Article
ISSN: 0270-9139
DOI: 10.1002/hep.1840220408

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antipyrine clearance and response to int

Antipyrine clearance and response to interferon therapy in chronic hepatitis

✍ A Fabbri; G P Bianchi; G Marchesini 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB 👁 2 views

In a recent publication by Panzar et al., 1 the authors have 55. used 400-to 1,000-d polyethylene glycol to study small intes-4. Lake JR, Licko V, van Dyke RN, Scharschmidt BF. Biliary secretion of fluid-markers by the isolated perfused rat liver. J Clin Invest 1985;76:676-tinal absorption in portac

Immune response in chronic hepatitis C–i

Immune response in chronic hepatitis C–infected patients undergoing interferon treatment

✍ Antonietta Cargnel; Guido Gubertini; Carlo Magnani; Simona Bosis; Fulvia Colombo 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 24 KB 👁 1 views

The findings of Mason et al. 1 on diabetes mellitus and hepatitis C are similar to our own, reported at the 8th European Congress of Clinical Microbiology and Infectious Diseases. 2 In our study, diabetes was found in 34.7% and 2.7% of chronic hepatitis C and chronic hepatitis B patients, respective

Cellular immunity to hepatitis C virus c

Cellular immunity to hepatitis C virus core protein and the response to interferon in patients with chronic hepatitis C

✍ Juan-José Lasarte; Marta García-Granero; Ascensión López; Noelia Casares; Nicolá 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 2 views

To investigate the involvement of T-cell response against hepatitis C virus (HCV) antigens in viral clearance after interferon therapy, we measured interleukin-2 (IL-2) production by peripheral mononuclear cells in response to HCV core in patients with chronic hepatitis C. In a cohort of 43 patients

Genotypes and titers of hepatitis C viru

Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C

✍ Kunihiko Hino; Shigehiko Sainokami; Kazumi Shimoda; Shiro Iino; Yu Wang; Hiroaki 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 708 KB

## Abstract Interferon induces remission in about 50% of patients with chronic hepatitis C, but it is difficult to predict which patients will respond. Host and viral factors were evaluated for correlation with response to interferon in patients with chronic hepatitis C. Recombinant interferon alph

Virological response to interferon treat

Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis

✍ A Rossini; A Ravaggi; L Biasi; E Agostinelli; L Bercich; G B Gazzola; F Callea; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 238 KB 👁 2 views

Hepatitis C virus (HCV) carriers with normal aminotransferase levels often show histological chronic hepatitis. This study was undertaken to determine the effect of interferon (IFN) in such patients. Nineteen HCV carriers with normal aminotransferase activities and chronic hepatitis were randomized

Re-treatment with interferon alfa of pat

Re-treatment with interferon alfa of patients with chronic hepatitis C

✍ Wan-Cheng Chow; Nathalie Boyer; Michele Pouteau; Corinne Castelnau; Michele Mart 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Treatment of patients with chronic hepatitis C has had limited success because of relapses and nonresponse to interferon alfa therapy (currently the only established therapeutic agent). A retrospective study was done to determine the efficacy of re-treatment with interferon and the predictors of res